Leonite Fund I, LP 13D and 13G filings for Coeptis Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-11 12:27 pm Purchase |
2024-01-05 | 13G | Coeptis Therapeutics, Inc. COEP |
Leonite Fund I, LP | 102,500 6.000% |
102,500 (New Position) |
Filing |